Cost of insured cancer claims surge 131%

Growing corporate demand for private healthcare

Jaskeet Briah
clock • 2 min read

The cost of claims being paid by insurers has jumped as patients require more complex treatment, as delayed or missed diagnoses often delay necessary care, according to new data from Broadstone.

The independent consultancy analysed the volume and cost of corporate healthcare claims, finding that for cancer claims, the number of claimants rose 20% but the cost of claims paid surged 131% as severity increased. According to the latest NHS data, 64% of people in England received their diagnosis and started their first treatment within two months (or 62 days) of an urgent referral in February 2024, despite the target being 85%. Brett Hill, head of health and protection, Broadstone, said: "Soaring waiting lists and a surge in the number of patients per GP are causing delays to trea...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on PMI

Emma Thomson joins Reframe Cancer as consultant
PMI

Emma Thomson joins Reframe Cancer as consultant

Shaping protection proposition

Jaskeet Briah
clock 03 December 2024 • 2 min read
Record quarter for private hospital admissions
PMI

Record quarter for private hospital admissions

PHIN data

Cameron Roberts
clock 03 December 2024 • 2 min read
AXA Health names HBSUK CEO
PMI

AXA Health names HBSUK CEO

Supporting faster access to treatment

Jaskeet Briah
clock 03 December 2024 • 1 min read